🇺🇸 FDA
Pipeline program

Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers

IMC-P115C-1005

Phase 1 other active

Quick answer

Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers for Advanced PRAME Positive Cancers is a Phase 1 program (other) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Immunocore Ireland Limited
Indication
Advanced PRAME Positive Cancers
Phase
Phase 1
Modality
other
Status
active

Clinical trials